Healthy liver-cell transplants may help treat genetic liver-lung disorder
April 23rd, 2011 - 3:36 pm ICT by ANIWashington, April 23 (ANI): A animal study has found that transplanting cells from healthy adult livers may work in treating a genetic liver-lung disorder that affects millions of people worldwide.
The genetic disorder, alpha-1 antitrypsin (AAT) deficiency, is the most common potentially lethal hereditary disease among Caucasians. AAT is a protein made by the liver that is essential for lung health. In AAT deficiency, the liver produces a misshapen form of AAT that cannot enter the bloodstream and instead gets stuck inside liver cells, causing two major problems - fibrosis (development of scar tissue) and liver failure.
Too little AAT reaches the lungs, where it’s needed to rein in elastase, an enzyme produced by white blood cells. Elastase helps kill bacteria in the lungs, but uncontrolled elastase activity can damage lung tissue and lead to severe emphysema (chronic obstructive pulmonary disease).
In the study, Jayanta Roy-Chowdhury, professor of medicine and of genetics at Albert Einstein College of Medicine of Yeshiva University, and his colleagues tested cell therapy on transgenic mice whose liver cells (hepatocytes) had been engineered to produce mutant human AAT, resulting in liver fibrosis. When the mice were given infusions of hepatocytes harvested from the livers of healthy mice, the transplanted cells proliferated in the host liver, progressively replacing diseased hepatocytes.
Most importantly, the transplanted cells reversed the fibrosis that had developed, said Roy-Chowdhury
“These promising results in animals indicate that it may be worthwhile to investigate the usefulness of hepatocyte transplantation for AAT deficiency as well as a variety of other inherited liver-based disorders,” said Roy-Chowdhury.
The study has been published in the Journal of Clinical Investigation. (ANI)
- Gene therapy to prevent lung disease progression discovered - Dec 22, 2009
- Cholesterol regulator plays key role in development of liver fibrosis - Mar 31, 2011
- Seizure drug could help treat severe genetic liver disease - Jun 04, 2010
- New study paves for novel treatments for regenerating liver, bone marrow - Nov 13, 2010
- Chronic liver disease cure on the horizon - Mar 06, 2012
- Protein that controls liver stem cells, prevents tumor development found - Aug 13, 2010
- New hope for patients with end-stage liver disease - Jan 12, 2011
- Healing damaged liver tissues - Dec 05, 2011
- 'Jekyll and Hyde' cell paves way for muscular dystrophy, fibrosis treatment - Jan 19, 2010
- Protein involved in cystic fibrosis linked to chronic lung diseases - Dec 30, 2010
- Second-hand smoke 'triggers inflammatory response in lungs' - Aug 27, 2010
- Chronic inhalation of polluted air 'can lead to inflammation, heart risk' - Apr 17, 2011
- Placenta-derived stem cells may help treat lung diseases - Jul 28, 2009
- Vitamin D deficiencies linked to onset of autoimmune lung disease - Jan 04, 2011
- Mums' stem cells could be key to treating genetic disease before birth - Jan 19, 2011
Tags: albert einstein, albert einstein college, albert einstein college of medicine, albert einstein college of medicine of yeshiva universi, cell transplants, chronic obstructive pulmonary disease, einstein college of medicine, healthy liver, hereditary disease, journal of clinical investigation, liver cell, liver cells, liver failure, liver fibrosis, lung disorder, obstructive pulmonary disease, roy chowdhury, scar tissue, transgenic mice, white blood cells